FasT CAR-T Is Faster, More Potent and Affordable Therapy, Gracell Bio Says
News
Gracell Biotechnologies has developed a platform, called FasT CAR-T, that is able to manufacture its CD19-targeting CAR T-cell product in a single day, as opposed to 14 days for conventional ... Read more